What Summit Therapeutics Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 6 |
| Sells | 0 | 0 |
| Total trades | 1 | 7 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 100,000 | 7,970,000 |
| Disposed | 0 | 0 |
| Net activity | +100,000 | +7,970,000 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Anand Bhaskar | Chief Accounting Officer | Oct 08 | Grant / award · A | +100,000 | — | — | 261,047 |
| Duggan Robert W | Co-Chief Executive Officer | Jun 12 | Open-market buy · P | +3,810,000 | $13.12 | +$50M | 573,883,879 |
| Zanganeh Maky | Co-Chief Executive Officer | Jun 12 | Open-market buy · P | +3,810,000 | $13.12 | +$50M | 573,883,879 |
| Soni Manmeet Singh | COO and CFO | Jun 04 | Open-market buy · P | +25,000 | $14.43 | +$361K | 3,123,603 |
| Soni Manmeet Singh | COO and CFO | Jun 04 | Open-market buy · P | +25,000 | $14.46 | +$362K | 3,098,603 |
| Zanganeh Maky | Co-Chief Executive Officer | Jun 04 | Open-market buy · P | +100,000 | $14.60 | +$1.46M | 25,824,474 |
| Duggan Robert W | Co-Chief Executive Officer | Jun 04 | Open-market buy · P | +100,000 | $14.60 | +$1.46M | 25,824,474 |
| Zanganeh Maky | Co-Chief Executive Officer | Oct 21 | Grant / award · A | +13,980,789 | $18.74 | +$262M | 570,073,879 |
| Zanganeh Maky | Co-Chief Executive Officer | Oct 21 | Open-market buy · P | +26,680 | $18.74 | +$500K | 76,680 |
| Zanganeh Maky | Co-Chief Executive Officer | Oct 21 | Grant / award · A | +266,808 | $18.74 | +$5M | 25,724,474 |
| Duggan Robert W | Co-Chief Executive Officer | Oct 21 | Open-market buy · P | +26,680 | $18.74 | +$500K | 76,680 |
| Duggan Robert W | Co-Chief Executive Officer | Oct 21 | Grant / award · A | +266,808 | $18.74 | +$5M | 25,724,474 |
| Duggan Robert W | Co-Chief Executive Officer | Oct 21 | Grant / award · A | +13,980,789 | $18.74 | +$262M | 570,073,879 |
| Soni Manmeet Singh | COO and CFO | Oct 21 | Grant / award · A | +53,361 | $18.74 | +$1M | 3,073,603 |
| Xia Yu | Director | Oct 21 | Open-market buy · P | +533,617 | $18.74 | +$10M | 32,057,147 |
| Anand Bhaskar | Chief Accounting Officer | Oct 21 | Grant / award · A | +26,680 | $18.74 | +$500K | 159,751 |
| Duggan Robert W | Co-Chief Executive Officer | Sep 11 | Open-market buy · P | +5,000 | $18.07 | +$90.4K | 556,093,090 |
| Zanganeh Maky | Co-Chief Executive Officer | Sep 11 | Open-market buy · P | +5,000 | $18.07 | +$90.4K | 556,093,090 |
| Duggan Robert W | Co-Chief Executive Officer | Sep 10 | Open-market buy · P | +333,394 | $17.68 | +$5.89M | 556,088,090 |
| Zanganeh Maky | Co-Chief Executive Officer | Sep 10 | Open-market buy · P | +333,394 | $17.68 | +$5.89M | 556,088,090 |
Loading...
